E
Errol B. De Souza
Researcher at National Institute on Drug Abuse
Publications - 60
Citations - 4038
Errol B. De Souza is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Receptor & Pituitary gland. The author has an hindex of 34, co-authored 60 publications receiving 3988 citations. Previous affiliations of Errol B. De Souza include Loyola University Chicago & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Corticotrophin-releasing factor receptors: from molecular biology to drug design
Derek T. Chalmers,Timothy W. Lovenberg,Dimitri E. Grigoriadis,Dominic P. Behan,Errol B. De Souza +4 more
TL;DR: The major differences between the two classes of CRF receptors, CRF1 and CRF2, and a functionally related CRF-binding protein are highlighted, and the relevance of these sites to the ongoing development ofCRF-based therapeutics is discussed.
Journal ArticleDOI
MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
TL;DR: The neurodegenerative effects of MDMA on5-HT neurons exhibited some species specificity as comparable decreases in cerebral cortical 5-HT, 5-HIAA and 5- HT uptake sites were observed in rat and guinea pig while no significant changes in any of these serotonergic parameters were seen in mouse brain.
Journal ArticleDOI
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
TL;DR: MDMA exhibited negligible affinities (greater than 500 microM) at opioid (mu, delta and kappa), central-type benzodiazepine, and corticotropin-releasing factor receptors, and at choline uptake sites and calcium channels.
Journal ArticleDOI
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
Errol B. De Souza,Errol B. De Souza,Peter J. Whitehouse,Michael J. Kuhar,Michael J. Kuhar,Donald L. Price,Wylie Vale +6 more
TL;DR: In Alzheimer’s, the concentrations of CRF-like immunoreactivity (CRF-IR) are reduced and that there are reciprocal increases in CRF receptor binding in affected cortical areas, which strongly support a neurotransmitter role for CRF in brain and demonstrate, for the first time, a modulation of CNS CRF receptors associated with altered CRF content.
Journal ArticleDOI
Peripheral-Type Benzodiazepine Receptors in Endocrine Organs: Autoradiographic Localization in Rat Pituitary, Adrenal, and Testis*
Errol B. De Souza,Robert R. H. Anholt,Kenneth M.M. Murphy,Solomon H. Snyder,Michael J. Kuhar +4 more
TL;DR: A differential and discrete localization of peripheral-type benzodiazepine receptors in rat pituitary, adrenal, and testis is demonstrated.